| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLE |
From the Department of Psychiatry (W.C., C.T.), University of Iowa, Iowa City, IA; Department of Psychiatry (A.L.), Cornell Medical College, Ithaca, NY; National Institute of Mental Health (J.D.M.), Bethesda, MD; Rhode Island Hospital (D.S.), Providence, RI; Department of Research Assessment and Training (J.E.), New York State Psychiatric Institute, New York; and Butler Hospital (T.M., M.K.), Providence, RI.
Address reprint requests to: William Coryell, MD, University of Iowa College of Medicine, Psychiatry ResearchMEB, Iowa City, IA 52242-1000. Email: william-coryell{at}uiowa.edu
OBJECTIVE: Studies of both community and clinical samples have associated depressive symptoms with risks for subsequent cardiovascular morbidity and mortality. Because the physiological mechanisms thought to underlie this link would be cumulative in their effects, the following analyses tested the prediction that risks for cardiovascular death would increase in proportion to the persistence of depressive symptoms in a long-term follow-up.
METHODS: Baseline assessment was performed as patients sought treatment for major depressive disorder, mania, or schizoaffective disorder. Follow-up evaluations occurred semiannually for the next 5 years and annually thereafter. The 903 patients described, observed for a mean of 11.0 years (SD = 5.2 years), were divided into thirds according to the proportion of follow-up weeks in episodes of major depressive disorder, schizoaffective disorder, or intermittent depressive disorder. The resulting groups were then compared by cumulative risks of cardiovascular death.
RESULTS: Patients whose depressive symptoms were the most persistent were no more likely to die of cardiovascular causes than were those with the fewest weeks ill. A regression analysis showed that older age and the presence of cardiovascular disease at baseline, but not the subsequent chronicity of depressive symptoms, predicted cardiovascular death.
CONCLUSIONS: The physiological concomitants of depressive illness apparently do not promote cardiovascular mortality in a cumulative manner. Efforts should be directed toward identification of risk factors common to both lifetime depressive symptoms and cardiovascular morbidity.
Key Words: affective disorder cardiovascular mortality follow-up
Abbreviations: MDD = major depressive disorder; RDC = ResearchDiagnostic Criteria.
This article has been cited by other articles:
![]() |
J. G. Fiedorowicz, D. A. Solomon, J. Endicott, A. C. Leon, C. Li, J. P. Rice, and W. H. Coryell Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder Psychosom Med, July 1, 2009; 71(6): 598 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Morriss and F. A. Mohammed Metabolism, lifestyle and bipolar affective disorder J Psychopharmacol, November 1, 2005; 19(6_suppl): 94 - 101. [Abstract] [PDF] |
||||
![]() |
X. Zhang, S. L. Norris, E. W. Gregg, Y. J. Cheng, G. Beckles, and H. S. Kahn Depressive Symptoms and Mortality among Persons with and without Diabetes Am. J. Epidemiol., April 1, 2005; 161(7): 652 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Wulsin Does Depression Kill? Arch Intern Med, June 26, 2000; 160(12): 1731 - 1732. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |